1. Khaled, Noura, Sonnier, Nicolas, Molnar, Ioana, Privat, Maud, Bidet, Yannick. 2021. RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene. In American journal of cancer research, 11, 4568-4581. doi:. https://pubmed.ncbi.nlm.nih.gov/34659906/
2. Murakami, Kohei, Zhifeng, He, Suzuki, Takako, Kobayashi, Yasuhiro, Nakamura, Yukio. 2019. The Shisa3 knockout mouse exhibits normal bone phenotype. In Journal of bone and mineral metabolism, 37, 967-975. doi:10.1007/s00774-019-01014-y. https://pubmed.ncbi.nlm.nih.gov/31222549/
3. Tang, Sheng-Hui, Hsiao, Cheng-Wen, Chen, Wei-Liang, Chang, Jin-Biou, Yang, Bing-Heng. . Hypermethylation of SHISA3 DNA as a blood-based biomarker for colorectal cancer. In The Chinese journal of physiology, 64, 51-56. doi:10.4103/CJP.CJP_89_20. https://pubmed.ncbi.nlm.nih.gov/33642344/
4. Zhang, Jian, Li, Ying-Qin, Guo, Rui, Ma, Jun, Liu, Na. 2018. Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability. In Cancer research, 79, 747-759. doi:10.1158/0008-5472.CAN-18-1754. https://pubmed.ncbi.nlm.nih.gov/30573520/
5. Maffei, Rossana, Fiorcari, Stefania, Martinelli, Silvia, Luppi, Mario, Marasca, Roberto. 2017. Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide. In Leukemia & lymphoma, 59, 423-433. doi:10.1080/10428194.2017.1339872. https://pubmed.ncbi.nlm.nih.gov/28639485/
6. Tsai, Ming-Hong, Chen, Wen-Chi, Yu, Sung-Liang, Yen, Sou-Jhy, Yang, Ya-Chien. 2015. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis. In Annals of surgical oncology, 22 Suppl 3, S1481-9. doi:10.1245/s10434-015-4593-1. https://pubmed.ncbi.nlm.nih.gov/25968618/
7. Shahzad, Naveed, Munir, Tehreem, Javed, Mariam, Anjum, Rana Salman, Shakoori, Abdul Rauf. 2020. SHISA3, an antagonist of the Wnt/β-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer. In PloS one, 15, e0236192. doi:10.1371/journal.pone.0236192. https://pubmed.ncbi.nlm.nih.gov/32692756/
8. Shen, Zhisen, Zhou, Chongchang, Li, Jinyun, Lin, Lexi, Zhang, Yuna. 2017. SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma. In BioMed research international, 2017, 9058749. doi:10.1155/2017/9058749. https://pubmed.ncbi.nlm.nih.gov/28299336/
9. Chen, Chun-Chieh, Chen, Hsuan-Yu, Su, Kang-Yi, Yang, Ya-Chien, Yu, Sung-Liang. . Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer. In American journal of respiratory and critical care medicine, 190, 433-44. doi:10.1164/rccm.201312-2256OC. https://pubmed.ncbi.nlm.nih.gov/25036006/
10. Lin, Changchun, Wang, Weimin, Zhang, Deyin, Zhang, Xiaoxue, Zheng, Wenxin. 2023. Polymorphisms in SHISA3 and RFC3 genes and their association with feed conversion ratio in Hu sheep. In Frontiers in veterinary science, 9, 1010045. doi:10.3389/fvets.2022.1010045. https://pubmed.ncbi.nlm.nih.gov/36686193/
智鼠故事 
